查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1606508

日本血管外科和血管内手术市场 - 2024-2031

Japan Vascular Surgery and Endovascular Procedures Market - 2024-2031
出版日期: | 出版商: DataM Intelligence | 英文 197 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

概述

日本血管手术和血管内手术市场于 2023 年达到 1.225 亿美元，预计到 2031 年将达到 2.24 亿美元，在 2024-2031 年预测期间复合年增长率为 7.9%。

血管外科是一门医学专业，专注于诊断和治疗影响血管系统（包括动脉、静脉和淋巴管）的疾病和病症。这些结构对于全身血液和淋巴循环至关重要。血管外科医师进行传统的开放式手术和微创手术，以恢復血流或消除血管阻塞。血管内手术是微创技术，用于透过小穿刺或切口治疗血管疾病。这些手术涉及使用导管、电线和其他透过血管引导的装置来进行治疗，而不需要进行开放性手术。

在人口老化、血管疾病盛行率上升以及微创技术进步等因素的推动下，日本血管手术和血管内手术的市场需求一直稳定成长。例如，根据日本血管外科学会的数据，在动脉瘤治疗领域，登记了包括髂总动脉瘤在内的腹主动脉瘤（AAA）20,160例，其中61.6%接受了血管内动脉瘤修復术（EVAR）治疗。在 AAA 病例中，1,794 例（8.9%）登记为破裂 AAA。

市场动态：

驱动程式和限制

人口老化加剧

老龄化人口的增加正在显着推动日本血管手术和血管内手术市场的发展，预计将在预测期内推动该市场的发展。随着老年人口比例持续上升，血管疾病的盛行率也随之增加，而血管疾病在老年人中更为常见。这种人口结构的变化极大地影响了对传统血管手术和微创血管内治疗的需求。

随着人们年龄的增长，他们更容易患週边动脉疾病（PAD）、主动脉瘤、静脉曲张和中风等疾病，所有这些疾病通常都需要血管干预。例如，根据世界经济论坛的数据，日本的人口老化程度越来越严重。目前，该国超过十分之一的人年龄在 80 岁或以上。近三分之一的人口年龄超过 65 岁——估计为 3,623 万人。中风风险随着年龄的增长而增加，特别是由于颈动脉疾病，这是老年人常见的血管疾病

血管手术和血管内手术相关的高成本

与血管手术和血管内手术相关的高成本预计将阻碍预测期内市场的成长。血管内装置（例如支架、移植物和线圈）的製造和使用成本昂贵。

血管内动脉瘤修復 (EVAR) 需要专门的移植物和影像设备，其成本可能明显高于传统手术。例如，根据牛津学院的数据，EVAR 的平均医疗费用为每位患者 35,2000 日圆。

此外，根据国立卫生研究院进行的一项研究，开放性手术修復 (OR) 与 EVAR 的平均成本如下：诊断程序组合 (DPC) 分别为 632,370 日元和 490,050 日元，这一数字非常显着；麻醉费分别为 123,540 日圆和 86,220 日圆，材料分别为 257,770 日圆和 2,113,280 日圆。因此，开放式维修和 EVAR 的平均总成本分别为 1,825,830 日圆和 3,159,270 日圆。

目录

第 1 章：方法与范围

第 2 章：定义与概述

第 3 章：执行摘要

第 4 章：动力学

  • 影响因素
    • 司机
      • 人口老化加剧
      • 微创技术的进步
    • 限制
      • 血管手术和血管内手术相关的高成本
    • 机会
    • 影响分析

第 5 章：产业分析

  • 波特五力分析
  • 供应链分析
  • 定价分析
  • 专利分析
  • 监管分析
  • SWOT分析
  • 未满足的需求

第 6 章：按程序

  • 动脉瘤修復
  • 绕道手术
  • 颈动脉血管成形术和支架置放术
  • 血管内修復
  • 其他的

第 7 章：按产品类型

  • 支架和覆膜支架
  • 血管内工具
  • 剪刀和镊子
  • 持针器
  • 其他的

第 8 章：最终用户

  • 医院
  • 医院
  • 手术中心
  • 学术研究机构
  • 其他的

第 9 章：竞争格局

  • 竞争场景
  • 市场定位/份额分析
  • 併购分析

第 10 章：公司简介

  • Terumo Corporation
    • 公司概况
    • 产品组合和描述
    • 财务概览
    • 主要进展
  • Olympus Corporation
  • FUJIFILM Holdings Corporation
  • Mizuho Medical Co., Ltd.
  • Nipro Corporation
  • Shimadzu Corporation
  • SB-KAWASUMI LABORATORIES, INC.
  • ASAHI INTECC CO., LTD.
  • Medtronic plc
  • Boston Scientific Corporation

第 11 章：附录

简介目录
Product Code: PH8802

Overview

The Japan vascular surgery and endovascular procedures market reached US$ 122.5 million in 2023 and is expected to reach US$ 224.0 million by 2031, growing at a CAGR of 7.9% during the forecast period 2024-2031.

Vascular surgery is a medical specialty focused on diagnosing and treating diseases and conditions affecting the vascular system, which includes arteries, veins, and lymphatic vessels. These structures are essential for circulating blood and lymph throughout the body. Vascular surgeons perform both traditional open surgeries and minimally invasive procedures to restore blood flow or remove blockages in the vessels. Endovascular procedures are minimally invasive techniques used to treat vascular conditions through small punctures or incisions. These procedures involve the use of catheters, wires, and other devices guided through blood vessels to perform treatments without the need for open surgery.

The market demand for vascular surgery and endovascular procedures in Japan has been growing steadily, driven by factors such as the aging population, rising prevalence of vascular diseases, and advancements in minimally invasive technologies. For instance, according to the Japanese Society for Vascular Surgery, in the field of aneurysm treatment, 20,160 cases of abdominal aortic aneurysm (AAA) including common iliac aneurysms were registered, and 61.6% were treated by endovascular aneurysm repair (EVAR). Among AAA cases, 1,794 (8.9%) cases were registered as ruptured AAA.

Market Dynamics: Drivers & Restraints

Rising aging population

The rising aging population is significantly driving the Japan vascular surgery and endovascular procedures market and is expected to drive the market over the forecast period. As the proportion of elderly people continues to rise, there is an increased prevalence of vascular diseases, which are more common among older individuals. This demographic shift is significantly impacting the demand for both traditional vascular surgery and minimally invasive endovascular treatments.

As people age, they are more susceptible to conditions like peripheral arterial disease (PAD), aortic aneurysms, varicose veins, and stroke all of which often require vascular interventions. For instance, according to the World Economic Forum, Japan is getting ever greyer. More than 1 in 10 people in the country are now aged 80 or older. Almost a third of its population is over 65 - an estimated 36.23 million. Stroke risk rises with age, particularly due to carotid artery disease, which is a common vascular condition in older people

High cost associated with vascular surgery and endovascular procedures

The high cost associated with vascular surgery and endovascular procedures is expected to hamper the growth of the market over the forecast period. Endovascular Devices such as stents, grafts, and coils are expensive to manufacture and use.

The cost of Endovascular Aneurysm Repair (EVAR), which requires specialized grafts and imaging equipment, can be significantly higher than traditional surgery. For instance, according to the Oxford Academy, the average medical cost for EVAR was 35,2000 Japanese Yen per patient.

Additionally, according to a study conducted by the National Institute of Health, the mean costs for open surgical repair (OR) versus EVAR were as follows, Diagnosis Procedure Combination (DPC) ¥632,370 versus ¥490,050, respectively, which was significant; anesthesia, ¥123,540 versus ¥86,220, respectively and materials, ¥257,770 versus ¥2,113,280, respectively. Thus, the mean total cost was ¥1,825,830 versus ¥3,159,270 for open repair and EVAR, respectively.

Segment Analysis

The Japan vascular surgery and endovascular procedures market is segmented based on procedure, product type and end-user.

Procedure:

The endovascular repair segment is expected to dominate the Japan vascular surgery and endovascular procedures market share

The endovascular repair segment holds a major portion of the Japan vascular surgery and endovascular procedures market share and is expected to continue to hold a significant portion of the market share over the forecast period. Endovascular repair involves the use of minimally invasive techniques to treat vascular conditions such as abdominal aortic aneurysms (AAA) and peripheral arterial disease (PAD). These procedures use small incisions or punctures, making them far less invasive than traditional open surgery.

The demand for EVAR has surged in Japan as patients prefer less invasive procedures that offer faster recovery times and shorter hospital stays. For instance, according to the J-Stage, as of 2020, EVAR accounted for over 60% of AAA cases in Japan, indicating its dominance in the treatment of aneurysms.

Endovascular repair has benefited from technological innovations in medical devices, imaging, and procedural techniques. The introduction of advanced stents, drug-eluting balloons and robotic-assisted navigation has made endovascular repair even more efficient, safe, and accessible. This has contributed to the widespread adoption of these procedures across Japan.

Competitive Landscape

The major Japan players in the vascular surgery and endovascular procedures market include Terumo Corporation, Olympus Corporation, FUJIFILM Holdings Corporation, Mizuho Medical Co., Ltd., Nipro Corporation, Shimadzu Corporation, SB-KAWASUMI LABORATORIES, INC., ASAHI INTECC CO., LTD., Medtronic plc, Boston Scientific Corporation and among others.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The Japan vascular surgery and endovascular procedures market report would provide approximately 39 tables, 31 figures and 197 pages.

Target Audience 2023

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Procedure
  • 3.2. Snippet by Product Type
  • 3.3. Snippet by End-User

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rising Aging Population
      • 4.1.1.2. Advancements in Minimally Invasive Techniques
    • 4.1.2. Restraints
      • 4.1.2.1. High Cost Associated with Vascular Surgery and Endovascular Procedures
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Patent Analysis
  • 5.5. Regulatory Analysis
  • 5.6. SWOT Analysis
  • 5.7. Unmet Needs

6. By Procedure

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure
    • 6.1.2. Market Attractiveness Index, By Procedure
  • 6.2. Aneurysm Repair*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Bypass Surgery
  • 6.4. Carotid Angioplasty and Stenting
  • 6.5. Endovascular Repair
  • 6.6. Others

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type
  • 7.2. Stents and Stent Grafts*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Endovascular Tools
  • 7.4. Scissors and Forceps
  • 7.5. Needle Holders
  • 7.6. Others

8. By End-User

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.1.2. Market Attractiveness Index, By End-User
  • 8.2. Hospitals*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Hospitals
  • 8.4. Surgical Centers
  • 8.5. Academic and Research Institutions
  • 8.6. Others

9. Competitive Landscape

  • 9.1. Competitive Scenario
  • 9.2. Market Positioning/Share Analysis
  • 9.3. Mergers and Acquisitions Analysis

10. Company Profiles

  • 10.1. Terumo Corporation*
    • 10.1.1. Company Overview
    • 10.1.2. Product Portfolio and Description
    • 10.1.3. Financial Overview
    • 10.1.4. Key Developments
  • 10.2. Olympus Corporation
  • 10.3. FUJIFILM Holdings Corporation
  • 10.4. Mizuho Medical Co., Ltd.
  • 10.5. Nipro Corporation
  • 10.6. Shimadzu Corporation
  • 10.7. SB-KAWASUMI LABORATORIES, INC.
  • 10.8. ASAHI INTECC CO., LTD.
  • 10.9. Medtronic plc
  • 10.10. Boston Scientific Corporation

LIST NOT EXHAUSTIVE

11. Appendix

  • 11.1. About Us and Services
  • 11.2. Contact Us